Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Completes $600M Acquisition of Caliper

Premium

PerkinElmer said this week that it has completed its acquisition of Caliper Life Sciences for around $600 million.

The agreement, which was announced in September, will, among other things, allow PerkinElmer to combine its expertise in informatics with Caliper's automation and sample-prep technology to bolster PerkinElmer's presence in the next-generation sequencing space (IS 9/13/2011).

In a statement, PerkinElmer CEO Robert Friel said that the deal will "strengthen PerkinElmer's position in personalized medicine."

As part of the deal, Caliper CEO Kevin Hrusovsky will join PerkinElmer as president of life sciences and technology to lead a newly created $500 million business that integrates Caliper with PerkinElmer's research business. Hrusovsky said the business will give "customers the tools and insights" to "understand the origins of disease, create new therapies, and transform personalized medicine."

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.